TACC3 expression as a prognostic factor in aggressive types of adult T-cell leukemia/lymphoma patients.

CONCLUSION: Certain drugs that inhibit TACC3-overexpressing neoplastic cells are used clinically. Further studies might highlight a key role for TACC3 in the oncogenesis and progression of ATLL.
PMID: 32744749 [PubMed - as supplied by publisher]

Source: International Journal of Laboratory Hematology - August 2, 2020 Category: Hematology Authors: Moritsubo M, Miyoshi H, Matsuda K, Yoshida N, Nakashima K, Yanagida E, Yamada K, Takeuchi M, Suzuki T, Muta H, Umeno T, Furuta T, Seto M, Ohshima K Tags: Int J Lab Hematol Source Type: research